Literature DB >> 21336759

Animal models for meningococcal disease.

A R Gorringe1, K M Reddin, P Voet, J T Poolman.   

Abstract

There are many in vitro systems for the study of meningococcal pathogenesis, but it is only in animal models of infection that the interactions of the bacteria with whole tissues and the humoral and cellular immune systems can be assessed. Animal-infection models are also of great importance for the assessment of the protective efficacy of existing and candidate vaccines. However, the relevance of these animal models to human disease and how well protection assessed in them corresponds to protection against human disease, must always be considered. Animal models for pathogenic Neisseria have been previously reviewed (1).

Entities:  

Year:  2001        PMID: 21336759     DOI: 10.1385/1-59259-148-5:241

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  7 in total

1.  Discordant Effects of Licensed Meningococcal Serogroup B Vaccination on Invasive Disease and Nasal Colonization in a Humanized Mouse Model.

Authors:  Carolyn M Buckwalter; Elissa G Currie; Raymond S W Tsang; Scott D Gray-Owen
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

2.  Invasive potential of nonencapsulated disease isolates of Neisseria meningitidis.

Authors:  Kay O Johswich; Jianwei Zhou; Dennis K S Law; Frank St Michael; Shannon E McCaw; Frances B Jamieson; Andrew D Cox; Raymond S W Tsang; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2012-04-16       Impact factor: 3.441

3.  Slam is an outer membrane protein that is required for the surface display of lipidated virulence factors in Neisseria.

Authors:  Yogesh Hooda; Christine Chieh-Lin Lai; Andrew Judd; Carolyn M Buckwalter; Hyejin Esther Shin; Scott D Gray-Owen; Trevor F Moraes
Journal:  Nat Microbiol       Date:  2016-02-29       Impact factor: 17.745

4.  Infection with an avirulent phoP mutant of Neisseria meningitidis confers broad cross-reactive immunity.

Authors:  J Newcombe; L-J Eales-Reynolds; L Wootton; A R Gorringe; S G P Funnell; S C Taylor; J J McFadden
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Neisseria lactamica protects against experimental meningococcal infection.

Authors:  Kerry J Oliver; Karen M Reddin; Philippa Bracegirdle; Michael J Hudson; Ray Borrow; Ian M Feavers; Andrew Robinson; Keith Cartwright; Andrew R Gorringe
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

6.  The macrophage scavenger receptor A is host-protective in experimental meningococcal septicaemia.

Authors:  Annette Plüddemann; J Claire Hoe; Katherine Makepeace; E Richard Moxon; Siamon Gordon
Journal:  PLoS Pathog       Date:  2009-02-13       Impact factor: 6.823

7.  Acute kidney injury in a mouse model of meningococcal disease.

Authors:  Karin R Kolbe; Talita R Sanches; Camilla Fanelli; Margoth R Garnica; Letícia Urbano de Castro; Karen Gooch; Stephen Thomas; Stephen Taylor; Andrew Gorringe; Irene de L Noronha; Lucia Andrade
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.